MyChesCo on MSN22h
ChromaTan and Landmark Bio Receive NIIMBL Grant to Advance AAV Gene Therapy Manufacturing
ChromaTan Inc. and Landmark Bio PBLLC have been awarded a grant from the National Institute for Innovation in Manufacturing ...
IFLScience on MSN5d
Vaccine-In-A-Pill For Norovirus, The Infamous Winter Bug, Performs Well In Early Trials
A vaccine against norovirus, the dreaded “winter vomiting bug”, could be closer than you think: early clinical trials have ...
Fierce Biotech2d
Flagship-backed Apriori Bio lays off employees, shifts focus to pipeline development
Apriori Bio has become the latest Flagship Pioneering-backed biotech to shed staff, cutting 15 workers to leave 21 still ...
GEN - Genetic Engineering and Biotechnology News1d
DMD Patient Dies After Treatment with Sarepta Gene Therapy
The patient, whom Sarepta described as a young man and later told news outlets was 16 years old, suffered acute liver failure ...
Bionova Scientific's $100 million project in The Woodlands close to starting, filing says
After scoring tax abatements for a $100 million investment in The Woodlands last year, the company appears to be close to beginning the project.
BioPharma Dive9d
3 ways to accelerate development and de-risk cell and gene therapy manufacturing
Development strategies designed to reduce the unknowns so that cell and gene therapy innovators can develop robust processes ...
Transgene to Participate in Upcoming Investor Meetings
Strasbourg (France), March 11, 2025, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today ...
Contract Pharma2d
ChromaTan and Landmark Bio Receive NIIMBL Grant
Funds will help the companies create a platform for the manufacturing and characterization of AAV-based gene therapy vectors.